We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current IGX market cap is 101.3M. The company's latest EPS is USD -0.0612 and P/E is -3.43.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.82M | 742k | 1.54M | 1.54M | 950k |
| Operating Income | -9M | -9.55M | -6.26M | -7.98M | -9.41M |
| Net Income | -10.11M | -10.66M | -7.04M | -9.31M | -10.69M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.02M | 11.02M | 11.12M | 17.91M | 9.19M |
| Total Liabilities | 10.03M | 10.73M | 12.07M | 14.03M | 12.61M |
| Total Equity | 9.99M | 293k | -953k | 3.87M | -3.42M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.53M | -8.2M | -5.77M | -7.17M | -9.52M |
| Investing | -2.18M | 3.21M | -526k | -5.07M | 3.51M |
| Financing | 16.4M | -690k | 6.24M | 15.49M | 2.97M |
| Market Cap | 101.3M |
| Price to Earnings Ratio | -3.43 |
| Price to Sales Ratio | 38.89 |
| Price to Cash Ratio | 30.43 |
| Price to Book Ratio | -10.72 |
| Dividend Yield | - |
| Shares Outstanding | 174.66M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.11 (16.92%) |
| Company Name | Intelgenx Technologies Corp |
| Address |
6420 abrams, ville saint laurent quebec city, quebec H4S 1Y2 |
| Website | https://www.intelgenx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
